258 related articles for article (PubMed ID: 35229451)
21. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
Ye J; Wu D; Shen J; Wu P; Ni C; Chen J; Zhao J; Zhang T; Wang X; Huang J
Mol Med Rep; 2012 Sep; 6(3):507-12. PubMed ID: 22684815
[TBL] [Abstract][Full Text] [Related]
22. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
[TBL] [Abstract][Full Text] [Related]
23. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
[TBL] [Abstract][Full Text] [Related]
24. Rat Bone Marrow-Derived Mesenchymal Stem Cells Promote the Migration and Invasion of Colorectal Cancer Stem Cells.
Zou W; Zhao J; Li Y; Wang Z; Yan H; Liu Y; Sun M; Zhuang J; Wang J
Onco Targets Ther; 2020; 13():6617-6628. PubMed ID: 32764957
[TBL] [Abstract][Full Text] [Related]
25. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
26. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
27. miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer.
Karimi Dermani F; Amini R; Saidijam M; Najafi R
J Cell Biochem; 2018 Jul; 119(7):6288-6295. PubMed ID: 29663476
[TBL] [Abstract][Full Text] [Related]
28. miR‑196a‑5p modulates gastric cancer stem cell characteristics by targeting Smad4.
Pan Y; Shu X; Sun L; Yu L; Sun L; Yang Z; Ran Y
Int J Oncol; 2017 Jun; 50(6):1965-1976. PubMed ID: 28440445
[TBL] [Abstract][Full Text] [Related]
29. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
Liu Z; Wang N; Wang F; Zhang S; Ding J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
[TBL] [Abstract][Full Text] [Related]
30. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Dzobo K; Sinkala M
OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518
[TBL] [Abstract][Full Text] [Related]
31. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
32. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
[TBL] [Abstract][Full Text] [Related]
33. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
Yeeravalli R; Kaushik K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
35. [Expression of DARS2 in colorectal cancer and its clinical significance].
Ma L; Yang HL; Huang SH; Huang LL; Wang CL; Mei JH
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):592-597. PubMed ID: 38825905
[No Abstract] [Full Text] [Related]
36. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
[TBL] [Abstract][Full Text] [Related]
37. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
[TBL] [Abstract][Full Text] [Related]
38. A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
La Fleur L; Johansson AC; Roberg K
PLoS One; 2012; 7(9):e44071. PubMed ID: 23049743
[TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract][Full Text] [Related]
40. Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells.
Kim MJ; Lee YS; Han GY; Lee HN; Ahn C; Kim CW
Biosci Biotechnol Biochem; 2015; 79(9):1438-46. PubMed ID: 25964982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
